NuChem Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Buyout/​LBO
  • Investors
  • 6

NuChem Therapeutics General Information

Description

Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of small molecule drug discovery. The company's services specialize in the field of medicinal chemistry, drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship design, DMPK services, computational drug design, enabling companies to move their project forward quickly and efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Discovery Tools (Healthcare)
Primary Office
  • 2350 rue Cohen
  • Saint-Laurent
  • Montreal, Quebec H4R 2N6
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NuChem Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Buyout/LBO (MBO) 22-Feb-2019 Completed Generating Revenue
1. Seed Round 03-Apr-2012 Completed Generating Revenue
To view NuChem Therapeutics’s complete valuation and funding history, request access »

NuChem Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Marc LeBel President & Board Member
Daniel Guay Ph.D Chief Scientific Officer
Lynda Choquette Director, Finance
Inès Holzbaur Ph.D President
To view NuChem Therapeutics’s complete executive team members history, request access »

NuChem Therapeutics Board Members (3)

Name Representing Role Since
Louis Lacasse GeneChem Board Member 000 0000
Marc LeBel NuChem Therapeutics President & Board Member 000 0000
To view NuChem Therapeutics’s complete board members history, request access »

NuChem Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fonds de solidarité FTQ PE/Buyout Minority 000 0000 000000 0
Investissement Québec Venture Capital Minority 000 0000 000000 0
GeneChem Venture Capital Minority 000 0000 000000 0
Institut De Recherche Clinique De Montreal Corporation Minority 000 0000 000000 0
Nabil Seidah Corporation Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

NuChem Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 31-Oct-2019 0000000000 Drug Discovery 0000 00000
To view NuChem Therapeutics’s complete investments history, request access »

NuChem Therapeutics Subsidiaries (1)

Company Name Industry Location Founded
000000 000000000 Drug Discovery Montreal, Canada 0000
To view NuChem Therapeutics’s complete subsidiaries history, request access »